Commercial Pharmaceutical Resale / Distribution
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the resale and distribution of commercially available pharmaceuticals under Federal Acquisition Regulation Part 12, focusing on efficient order fulfillment, end-to-end logistics management, and strict adherence to federal standards for delivery and invoicing. The work is performed as a subcontract under the Defense Logistics Agency, part of the Department of Defense, and is classified under NAICS code 424210 for pharmaceutical and chemical merchant wholesalers. All activities must comply with federal compliance requirements including timely delivery, accurate documentation, and proper handling of pharmaceutical products to ensure regulatory and operational integrity throughout the supply chain. The contract is effective as of August 5, 2026, and is administered through the DLA’s procurement system, with performance requirements centered on reliability and scalability to meet military and federal healthcare needs. The place of performance and specific delivery locations are not detailed, but the scope implies nationwide operations supporting defense medical facilities. Invoicing and shipping procedures must align precisely with federal guidelines to ensure seamless payment processing and audit readiness, with no set-aside designation applied to the procurement.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
